Guided by our values, Takeda's response to COVID-19 has focused on protecting the health and safety of our employees, our ability to ensure our medicines are available to patients who rely on them and playing our part to reduce transmission and support the communities where our employees live and work.
We are also leveraging our industry expertise and taking steps to help those impacted by the coronavirus. Takeda and other world-leading plasma companies have come together to focus on developing a hyperimmune globulin in the global fight against COVID-19. If you live in the United States and have recovered from COVID-19, your plasma may have the power to help others through a potential therapy.
Working together to fight COVID-19 with immunoglobulin(Ig) therapy.
Takeda is a proud member of the COVID R&D Alliance focused on finding treatments through shared expertise, data, and evaluation of drug candidates.
Takeda has aligned around a set of guiding principles that inform our decisions and actions, in response to the COVID-19 pandemic.
Latest updates on Takeda's efforts to address COVID-19.